Kyeremateng SO - Search Results

1

Phase behavior of pharmaceutically relevant polymer/solvent mixtures.

Dohrn S, Luebbert C, Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G. Dohrn S, et al. Among authors: kyeremateng so. Int J Pharm. 2020 Mar 15;577:119065. doi: 10.1016/j.ijpharm.2020.119065. Epub 2020 Jan 24. Int J Pharm. 2020. PMID: 31988034

2

Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage.

Theil F, Anantharaman S, Kyeremateng SO, van Lishaut H, Dreis-Kühne SH, Rosenberg J, Mägerlein M, Woehrle GH. Theil F, et al. Among authors: kyeremateng so. Mol Pharm. 2017 Jan 3;14(1):183-192. doi: 10.1021/acs.molpharmaceut.6b00783. Epub 2016 Nov 30. Mol Pharm. 2017. PMID: 28043131

3

Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.

Lehmkemper K, Kyeremateng SO, Heinzerling O, Degenhardt M, Sadowski G. Lehmkemper K, et al. Among authors: kyeremateng so. Mol Pharm. 2017 Jan 3;14(1):157-171. doi: 10.1021/acs.molpharmaceut.6b00763. Epub 2016 Dec 7. Mol Pharm. 2017. PMID: 28043133

4

Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.

Lehmkemper K, Kyeremateng SO, Heinzerling O, Degenhardt M, Sadowski G. Lehmkemper K, et al. Among authors: kyeremateng so. Mol Pharm. 2017 Dec 4;14(12):4374-4386. doi: 10.1021/acs.molpharmaceut.7b00492. Epub 2017 Nov 7. Mol Pharm. 2017. PMID: 29050468

5

Extraordinary Long-Term-Stability in Kinetically Stabilized Amorphous Solid Dispersions of Fenofibrate.

Theil F, Milsmann J, Kyeremateng SO, Anantharaman S, Rosenberg J, van Lishaut H. Theil F, et al. Among authors: kyeremateng so. Mol Pharm. 2017 Dec 4;14(12):4636-4647. doi: 10.1021/acs.molpharmaceut.7b00735. Epub 2017 Nov 16. Mol Pharm. 2017. PMID: 29111751

6

Physical stability of API/polymer-blend amorphous solid dispersions.

Lehmkemper K, Kyeremateng SO, Bartels M, Degenhardt M, Sadowski G. Lehmkemper K, et al. Among authors: kyeremateng so. Eur J Pharm Biopharm. 2018 Mar;124:147-157. doi: 10.1016/j.ejpb.2017.12.002. Epub 2017 Dec 18. Eur J Pharm Biopharm. 2018. PMID: 29269154

7

Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.

Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G. Lehmkemper K, et al. Among authors: kyeremateng so. Pharm Res. 2018 Jan 5;35(1):25. doi: 10.1007/s11095-017-2316-y. Pharm Res. 2018. PMID: 29305717

8

Development and Performance of a Highly Sensitive Model Formulation Based on Torasemide to Enhance Hot-Melt Extrusion Process Understanding and Process Development.

Evans RC, Kyeremateng SO, Asmus L, Degenhardt M, Rosenberg J, Wagner KG. Evans RC, et al. Among authors: kyeremateng so. AAPS PharmSciTech. 2018 May;19(4):1592-1605. doi: 10.1208/s12249-018-0970-y. Epub 2018 Feb 27. AAPS PharmSciTech. 2018. PMID: 29488197

9

Holistic QbD approach for hot-melt extrusion process design space evaluation: Linking materials science, experimentation and process modeling.

Evans RC, Bochmann ES, Kyeremateng SO, Gryczke A, Wagner KG. Evans RC, et al. Among authors: kyeremateng so. Eur J Pharm Biopharm. 2019 Aug;141:149-160. doi: 10.1016/j.ejpb.2019.05.021. Epub 2019 May 24. Eur J Pharm Biopharm. 2019. PMID: 31132400

10

Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.

Dohrn S, Reimer P, Luebbert C, Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G. Dohrn S, et al. Among authors: kyeremateng so. Mol Pharm. 2020 Jul 6;17(7):2721-2733. doi: 10.1021/acs.molpharmaceut.0c00418. Epub 2020 Jun 16. Mol Pharm. 2020. PMID: 32463685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters